[{
  "$type": "drugs.api",
  "origin": "Biological, protein, antibody",
  "drugNameSynonyms": [
        "anti-CD38 MAb (IV), Genmab",
        "anti-CD38 MAb (SC), Genmab",
        "anti-CD38 MAb, Genmab",
        "daratumumab"
  ],
  "recordUrl": "https://citeline.informa.com/#/drugs/details/33598",
  "drugCountries": [
        {
          "status": "Phase III Clinical Trial",
          "name": "Argentina",
          "licensingOpportunity": "N",
          "yearLaunched": "2017"
        },
        {
          "status": "Registered",
          "name": "Australia",
          "licensingOpportunity": "N"
        }
  ],
  "overview": "aaa",
  "chemicalStructure": [],
  "indicationGroups": [
        {
          "indications": [
                {
                  "diseaseName": "Amyloidosis, AL",
                  "diseaseStatus": "Phase III Clinical Trial"
                }
          ],
          "id": 14,
          "name": "Neurological Products"
        },
        {
          "indications": [
                {
                  "diseaseName": "Cancer, myeloma",
                  "diseaseStatus": "Launched"
                },
                {
                  "diseaseName": "Cancer, pancreatic",
                  "diseaseStatus": "Phase II Clinical Trial"
                }
          ],
          "id": 24,
          "name": "Rare Diseases"
        }
  ],
  "drugIcd9": [
        {
          "icd9Id": "ICD9CM:153.9",
          "name": "Malignant neoplasm of colon, unspecified site"
        },
        {
          "icd9Id": "ICD9CM:157.0",
          "name": "Malignant neoplasm of head of pancreas"
        }
  ],
  "phaseII": "aa",
  "licensing": "aa3",
  "pharmacokinetics": [
        {
          "model": "m1",
          "parameter": "p1",
          "unit": "u1"
        },
        {
          "model": "m2",
          "parameter": "p2",
          "unit": "u2"
        }
  ],
  "phaseI": "aaaaaaa",
  "latestChangeDate": "aaa1",
  "copyrightNotice": "Data from Pharmaprojects pipeline drug development monitoring database. Copyright Citeline, Inc. 2019.",
  "targets": [
        {
          "targetECNumbers": [
                "Enzyme > EC number > 3.2.2.5"
          ],
          "targetSynonyms": [
                "ADP-ribosyl cyclase",
                "CD38"
          ],
          "targetName": "CD38 molecule",
          "targetFamilies": [
                "Receptor"
          ],
          "entrezGeneId": 952
        }
  ],
  "casNumbers": [
        "945721-28-8"
  ],
  "drugPrimaryName": "daratumumab",
  "drugMeshTerms": [
        {
          "name": "Amyloidosis",
          "meshId": "D000686"
        },
        {
          "name": "Breast Neoplasms",
          "meshId": "D001943"
        }
  ],
  "marketing": "aaa",
  "phaseIII": "aa27",
  "latestChange": "Results of Phase III trial (COLUMBA; MMY3012) for multiple myeloma reported",
  "isPharmaProjectsDrug": "True",
  "originatorCompanyKey": "961",
  "drugId": 33598,
  "licensee": [
        {
          "licenseeStatus": "Launched",
          "licenseeCountry": "USA",
          "licenseeCompanyKey": 316,
          "licenseeName": "Johnson & Johnson"
        }
  ],
  "keyEvents": [
        {
          "keyEventHistory": "Nonproprietary Name Granted",
          "keyEventDetail": "HuMax-CD38",
          "keyEventDate": "2009-08-14T00:00:00Z"
        },
        {
          "keyEventHistory": "Drug Added",
          "keyEventDate": "2005-05-13T00:00:00Z"
        }
  ],
  "mechanismsOfAction": [
        "CD38 antagonist",
        "Immuno-oncology therapy"
  ],
  "drugIcd10": [
        {
          "name": "Malignant neoplasm of ascending colon",
          "icd10Id": "C18.2"
        },
        {
          "name": "Malignant neoplasm of hepatic flexure",
          "icd10Id": "C18.3"
        }
  ],
  "originatorCountry": "Denmark",
  "originatorStatus": "Launched",
  "drugSource": "NonClinicalTrials.gov",
  "globalStatus": "Launched",
  "deliveryRoutes": [
        "Inhaled",
        "Injectable, subcutaneous"
  ],
  "trialIds": [
        80740,
        143380,
        143381
  ],
  "drugSnomed": [
        {
          "name": "T-cell lymphoma",
          "snomedId": "SNOMED109978004"
        },
        {
          "name": "B-cell lymphoma",
          "snomedId": "SNOMED109979007"
        }
  ],
  "preClinical": "aaa",
  "originatorName": "Genmab",
  "therapeuticClasses": [
        {
          "therapeuticClassName": "aa1",
          "therapeuticClassStatus": "aa2"
        },
        {
          "therapeuticClassName": "aa3",
          "therapeuticClassStatus": "Launched"
        }
  ],
  "deliveryTechnologies": [],
  "deliveryMediums": [
        "aa"
  ],
  "patents": [
        {
          "patentNumber":"EP147193",
          "patentPriorityCountryDate":"1983-12-26T00:00:00.0000000Z"
    }
  ],
  "chemicalName": "aa234'",
  "originatorParentName": "aa",
  "originatorParentKey": "aaa",
  "molecularFormula": "22331",
  "molecularWeight": "20",
  "nce": "aa"
}]


